Chargement en cours...
Treatment of chronic hepatitis C in liver transplant candidates and recipients: Where do we stand?
The first generation direct antiviral agents (DAAs) highlighted substantial prognosis improvement among liver transplant (LT) candidates and recipients with recurrent hepatitis C virus (HCV) infection. During 2014, second generation DAAs are associated with high sustained virological response rates...
Enregistré dans:
| Publié dans: | World J Hepatol |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Inc
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4483543/ https://ncbi.nlm.nih.gov/pubmed/26140081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i12.1606 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|